Principles for Data Access & Utilization in Medical and Digital Health Technologies

Discover how AI is transforming medical technology with the AI Policy Packet. Learn how Congress can unleash even more innovation with targeted legislation. Download your copy today!

This white paper, “Connected Medical Devices”, explores the transformative impact of integrating Bluetooth Low Energy (BLE), mobile apps, cloud platforms, and AI/ML into medical devices. It highlights the benefits of real-time data exchange, remote monitoring, and enhanced clinical decision-making while addressing challenges such as security, FDA compliance, and data management. The document includes a case study on an implantable neural stimulator, outlines key design considerations, and discusses mobile and cloud-based platforms for connected healthcare solutions. Developed by Sunrise Labs, the paper provides insights into engineering best practices for next-generation medical devices.

Hear from AdvaMed®’s data privacy expert, Terry Chang, on the critical exemptions we seek in comprehensive data privacy laws across the country.

AdvaMed®’s digital health policy expert, Geeta Pamidimukkala, and payment and health care delivery policy expert, Kirsten Tullia, break down how artificial intelligence and machine learning (AI/ML) technologies are transforming patient care and the FDA’s crucial role in overseeing AI-powered medical devices.

Jones Lang Lasalle Inc. is the trusted real estate advisor to over 100 AdvaMed® members across the globe and will be presenting the tools and strategies they have employed to achieve facility savings and mitigate risk within this very dynamic real estate market.

AdvaMed®, the Medtech Association, commended the House of Representatives’ bipartisan Task Force on Artificial Intelligence for urging the Centers for Medicare & Medicaid Services (CMS) to develop a formalized payment pathway for AI-enabled medical devices. AI-enabled medical devices are FDA-cleared and produce clinical information to aid in patient diagnosis or treatment.

Join Porzio in this session that will help med device compliance leaders with messaging, designing, and implementing risk assessments, a key component of an effective healthcare compliance program.

This white paper explores the evolution of current biopharmaceutical commercial models. By addressing key considerations essential for every healthcare leader, this shares the impact of integrating
digital assets clinician engagement
and enhancing health outcomes.